โ
ูู Thiazid ู
ู
ูู ุชุฑูุน.LDL ูT. G ู
ุงุนุฏุง ุงู indapamide ูุน ุงูู
ุฏู ุงููุตูุฑ ุฎุงุตุฉ..
Black patient
Female
Diuretic resistance
ููู dose dependent
Black patient
Female
Diuretic resistance
ููู dose dependent
โค3
๐Sulindac
โ has become the NSAID of choice in some
centres for patients with renal impairment because of
reports of its renal sparing effects.
โ There is evidence
that this sparing effect is dose-related and is lost if
doses above 100 mg twice daily are used.
#Basel
Renal handbook
https://t.me/pharma_Note
โ has become the NSAID of choice in some
centres for patients with renal impairment because of
reports of its renal sparing effects.
โ There is evidence
that this sparing effect is dose-related and is lost if
doses above 100 mg twice daily are used.
#Basel
Renal handbook
https://t.me/pharma_Note
Telegram
Good pharmacists..โ๐๐จโโ
๐ฐ ููุงู ุชุญุชูู ุนูู ู
ุนููู
ุงุช_ ุทุจูุฉ ุญูู ุงูุงุฏููู ูุชุดุฎูุต ุงูุญุงูุงุช ุงูุณุฑูุฑูุฉ..๐๐๐จโโ.
ุฑุงุจุท ุงูููุงุฉ..
https://t.me/pharma_Note
ููุชูุงุตู ู ุน ุงูุฃุฏู ู :
@Basel_Alafif
ุฑุงุจุท ุงูููุงุฉ..
https://t.me/pharma_Note
ููุชูุงุตู ู ุน ุงูุฃุฏู ู :
@Basel_Alafif
โค4๐2
๐Which ARBs in "what if scenarios?
โ Enteropathyยป
All but olmesartan
โ gout-drug induced hepatotoxicityยป losartan, irbesartan
โ DM, Obesity, non alcohol fatty liverยป
Telimisartan, azilsartan
โ liver impairmentยป all but losartan
โ renal stones, polypharmacyยป
All but losartan
โ non compliantยป azilsartan
โ non-dipper, morning surge in BPยป
Telimsartan, irbesartan, candedsartan
#Basel
https://t.me/pharma_
โ Enteropathyยป
All but olmesartan
โ gout-drug induced hepatotoxicityยป losartan, irbesartan
โ DM, Obesity, non alcohol fatty liverยป
Telimisartan, azilsartan
โ liver impairmentยป all but losartan
โ renal stones, polypharmacyยป
All but losartan
โ non compliantยป azilsartan
โ non-dipper, morning surge in BPยป
Telimsartan, irbesartan, candedsartan
#Basel
https://t.me/pharma_
๐6โค2
โ๏ธูููุงุฆุฏุฉ ููุงู ุทุฑููุฉ ูุญุณุงุจ
antidote for heparin
โ ุงููุง ูุงุฒู ูุดูู ูู ูุฉ ุงูููุจุงุฑูู ุงูู ุนุทุงู ุงุฎุฑ ุณุงุนุชูู ุงูู ุซูุงุซ ุณุงุนุงุช.. ุซู
ูุนุทู ูุตููุง ุจุงูุฅุถุงูุฉ ูุนูู
ุซู ุฑุจุนูุง!
โป๏ธูู ุซูุง ูู ู ุฑูุถ ุจูุฃุฎุฐ 1000unite /h
ูู ุจุชููู ุฌุฑุนุฉ protamine ููุง ุ
ุจูููู 1000+500+250=1750unite
ูุงูู ุนุฑูู ุงู ูู ูุญุฏู ู ู ุงูููุจุงุฑูู ุจูุบุทููุง ุจ100mg ู ู protamine
ุงุฐุง 1750รท100=17.5mg
ูุจุงูุชุงูู ุงูุฌุฑุนุฉ ููุง ุจุชููู 17.5mg
๐ ู ูุญูุธู
ุงููุง ุงูmaximum dose 50mg
ุจุฅุณุชุซูุงุก CABG
๐ ุฃูุถุง ู ู ูู ูุนุชู ุฏ ุน ุงูููุช ูู ูุงู ู ุนุฑูู ูู ุง ู ูุถุญ ุจุงูุตูุฑุฉ ุงูุชุงูู๐
#Basel
https://t.me/pharma_Note
antidote for heparin
โ ุงููุง ูุงุฒู ูุดูู ูู ูุฉ ุงูููุจุงุฑูู ุงูู ุนุทุงู ุงุฎุฑ ุณุงุนุชูู ุงูู ุซูุงุซ ุณุงุนุงุช.. ุซู
ูุนุทู ูุตููุง ุจุงูุฅุถุงูุฉ ูุนูู
ุซู ุฑุจุนูุง!
โป๏ธูู ุซูุง ูู ู ุฑูุถ ุจูุฃุฎุฐ 1000unite /h
ูู ุจุชููู ุฌุฑุนุฉ protamine ููุง ุ
ุจูููู 1000+500+250=1750unite
ูุงูู ุนุฑูู ุงู ูู ูุญุฏู ู ู ุงูููุจุงุฑูู ุจูุบุทููุง ุจ100mg ู ู protamine
ุงุฐุง 1750รท100=17.5mg
ูุจุงูุชุงูู ุงูุฌุฑุนุฉ ููุง ุจุชููู 17.5mg
๐ ู ูุญูุธู
ุงููุง ุงูmaximum dose 50mg
ุจุฅุณุชุซูุงุก CABG
๐ ุฃูุถุง ู ู ูู ูุนุชู ุฏ ุน ุงูููุช ูู ูุงู ู ุนุฑูู ูู ุง ู ูุถุญ ุจุงูุตูุฑุฉ ุงูุชุงูู๐
#Basel
https://t.me/pharma_Note
๐1
โ๏ธRemember
alpha-blockers should generally not be
used as initial agents to treat hypertensionโ
โ๏ธexcept perhaps
in men with symptomatic prostatism or nightmares linked
to PTSD.
#Basel
Current medication 2024
alpha-blockers should generally not be
used as initial agents to treat hypertensionโ
โ๏ธexcept perhaps
in men with symptomatic prostatism or nightmares linked
to PTSD.
#Basel
Current medication 2024
โ๏ธRemember
โ Resistant hypertension:
Uncontrolled BP despite use of maximally tolerated dose of 3 antihypertensive drugs including diuretics.
โ Refractory hypertension:
Uncontrolled BP despite use of 5 or more antihypertensive agent of different classes including along acting thiazide like diuretic and an MR mineralocorticoid receptor antagonist at maximal or maximally tolerated dose .
#Basel
โ Resistant hypertension:
Uncontrolled BP despite use of maximally tolerated dose of 3 antihypertensive drugs including diuretics.
โ Refractory hypertension:
Uncontrolled BP despite use of 5 or more antihypertensive agent of different classes including along acting thiazide like diuretic and an MR mineralocorticoid receptor antagonist at maximal or maximally tolerated dose .
#Basel
๐2
โ๏ธRemember
โ Maximum time allowed for thrombolytic therapy in STEMI is 24h
โ Maximum time allowed for primary PCI in stable STEMI patients is 48h
#Basel
โ Maximum time allowed for thrombolytic therapy in STEMI is 24h
โ Maximum time allowed for primary PCI in stable STEMI patients is 48h
#Basel
โ๏ธRemember
โ Normal D-Dimer value for male patient above 50 years can be calculated as
Age *10 ug/L
#Basel
โ Normal D-Dimer value for male patient above 50 years can be calculated as
Age *10 ug/L
#Basel
๐3
โ๏ธ in UTI infection
Asymptomatic bacteriuria need to be treated only in:
โ pregnant women
โ patients undergoing urological intervention
โ renal transplant recipients in the first few months after transplant
#Basel
Asymptomatic bacteriuria need to be treated only in:
โ pregnant women
โ patients undergoing urological intervention
โ renal transplant recipients in the first few months after transplant
#Basel
๐5
โซThe definition of nephrotoxicity for vancomycin :
โ๏ธGenerally defined as minimum of 2 to 3 consecutive documented increases in serum creatinine levels:
1๏ธโฃIncrease of 0.5mg/ml for patients with scr WNL or
2๏ธโฃIncrease greater than 20%from baseline (especially for patients with abnormal baseline creatinine)
#Basel
IDSA
โ๏ธGenerally defined as minimum of 2 to 3 consecutive documented increases in serum creatinine levels:
1๏ธโฃIncrease of 0.5mg/ml for patients with scr WNL or
2๏ธโฃIncrease greater than 20%from baseline (especially for patients with abnormal baseline creatinine)
#Basel
IDSA
โค1๐1๐1
โ๏ธFosinopril is the only phosphinate-containing ACE inhibitor
โ๏ธ In contrast to other ACE inhibitors, fosinopril is eliminated from
the body via both renal and hepatic pathways, which make it a safer choice in patients
with impaired kidney function.
โ๏ธ In contrast to other ACE inhibitors, fosinopril is eliminated from
the body via both renal and hepatic pathways, which make it a safer choice in patients
with impaired kidney function.
โ๏ธTo administer Aminoglycoside antibiotics, for total dosing
โ For patientโs having weight is 1-1.2 times their ideal body weight, ideal body
weight is used.
โ For patients whose weighs more than 1.2 times ideal body weight, use adjusted
body weight is used
โ For patientโs having weight is 1-1.2 times their ideal body weight, ideal body
weight is used.
โ For patients whose weighs more than 1.2 times ideal body weight, use adjusted
body weight is used
โค2๐1
โ๏ธIn CKD the tubular secretory capacity for a diuretics is lowered offern in parallel with the reduction in GFR ,thus higher blood levels are required to effect tubular delivery sufficient to prompt a diuresis
ููุฐุง ุชูุถูุญ ููุณุคุงู ุงูุชุงูู..
ูู ุงุฐุง ูุฒูุฏ ุฌุฑุนู ุงูู ุฏุฑ ููู ุง ูู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู ุจุฎูุงู ุงูุนุงุฏุฉ ุงูู ูููุต ูููุง ุฌุฑุนุฉ ุงูุฏูุงุก ุนูุฏู ุง ููู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู.
#Basel
ููุฐุง ุชูุถูุญ ููุณุคุงู ุงูุชุงูู..
ูู ุงุฐุง ูุฒูุฏ ุฌุฑุนู ุงูู ุฏุฑ ููู ุง ูู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู ุจุฎูุงู ุงูุนุงุฏุฉ ุงูู ูููุต ูููุง ุฌุฑุนุฉ ุงูุฏูุงุก ุนูุฏู ุง ููู ู ุนุฏู ุงูุชุฑุดูุญ ุงููููู.
#Basel
โบInitial loop diuretics dosing in patients hospitalized with HF and congestion :
1โฃ For patientโs on long term 2.5ร their outpatient dose on a mg per mg basis ,demonstrated safety and efficacy
2โฃfor patients not receiving long term 40-80mg IV BID of furosemide or the equivalent .
ูุชูุถูุญ ุฑูู ูุงุญุฏ..
ูู ูุงู ุจูุฃุฎุฐ 40mg orally BIDู ุฑุชูู ุจุงูููู ุจุชููู
ุงูุฌุฑุนุฉ 100mg IV BID
ุงููุฏู ูู ูุน post dosing or post diurteic Na retention
ุงู ู ุง ุชู ุณู ุฃูุถุง
braking phenomenon
#Basel
https://t.me/pharma_Note
1โฃ For patientโs on long term 2.5ร their outpatient dose on a mg per mg basis ,demonstrated safety and efficacy
2โฃfor patients not receiving long term 40-80mg IV BID of furosemide or the equivalent .
ูุชูุถูุญ ุฑูู ูุงุญุฏ..
ูู ูุงู ุจูุฃุฎุฐ 40mg orally BIDู ุฑุชูู ุจุงูููู ุจุชููู
ุงูุฌุฑุนุฉ 100mg IV BID
ุงููุฏู ูู ูุน post dosing or post diurteic Na retention
ุงู ู ุง ุชู ุณู ุฃูุถุง
braking phenomenon
#Basel
https://t.me/pharma_Note
๐4
โ๏ธManagement of resistant HTN: Progress to next step if blood pressure remains uncontrolled
1โฃStep 1
โป๏ธ Exclude causes of HTN:
secondary causes, white-coat effect, medication nonadherence
โป๏ธ Maximize lifestyle interventions: low-sodium diet (<2400 mg/day), at least 6 hours/night of
uninterrupted sleep, weight loss, exercise)
โป๏ธOptimize three-drug regimen of CCB, RAS inhibitor, and diuretic (appropriately dosed for
renal function) at maximally tolerated doses.
2โฃStep 2: Substitute optimally dosed thiazide diuretic (chlorthalidone or indapamide) for previous diuretic
3โฃStep 3: Add mineralocorticoid (aldosterone) receptor antagonist: spironolactone or eplerenone
4โฃStep 4:
๐ดIf heart rate โฅ70 beats/min, add ฮฒ-blocker
๐ดIf ฮฒ-blocker is contraindicated, add central ฮฑ1-agonist (clonidine or guanfacine)
5โฃStep 5: Add hydralazine and titrate to maximal dose (use concomitantly with a ฮฒ-blocker and diuretic)
6โฃStep 6: Substitute minoxidil for hydralazine and titrate
7โฃStep 7: Refer to HTN specialist or ongoing clinical trial
#BASEL
#ACCP -ASHP - Cardiology 2023
1โฃStep 1
โป๏ธ Exclude causes of HTN:
secondary causes, white-coat effect, medication nonadherence
โป๏ธ Maximize lifestyle interventions: low-sodium diet (<2400 mg/day), at least 6 hours/night of
uninterrupted sleep, weight loss, exercise)
โป๏ธOptimize three-drug regimen of CCB, RAS inhibitor, and diuretic (appropriately dosed for
renal function) at maximally tolerated doses.
2โฃStep 2: Substitute optimally dosed thiazide diuretic (chlorthalidone or indapamide) for previous diuretic
3โฃStep 3: Add mineralocorticoid (aldosterone) receptor antagonist: spironolactone or eplerenone
4โฃStep 4:
๐ดIf heart rate โฅ70 beats/min, add ฮฒ-blocker
๐ดIf ฮฒ-blocker is contraindicated, add central ฮฑ1-agonist (clonidine or guanfacine)
5โฃStep 5: Add hydralazine and titrate to maximal dose (use concomitantly with a ฮฒ-blocker and diuretic)
6โฃStep 6: Substitute minoxidil for hydralazine and titrate
7โฃStep 7: Refer to HTN specialist or ongoing clinical trial
#BASEL
#ACCP -ASHP - Cardiology 2023
โค1